SB

Samsara BioCapital Portfolio holdings

AUM $969M
1-Year Est. Return 134.49%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+134.49%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$761M
AUM Growth
+$264M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
49
New
Increased
Reduced
Closed

Top Buys

1
+$185M
2
+$36.1M
3
+$28.7M
4
RXRX icon
Recursion Pharmaceuticals
RXRX
+$23M
5
JANX icon
Janux Therapeutics
JANX
+$13.5M

Top Sells

1
+$8.72M
2
+$5.19M
3
+$3.55M
4
VTGN icon
VistaGen Therapeutics
VTGN
+$2.71M
5
KRON
Kronos Bio
KRON
+$2.23M

Sector Composition

1 Healthcare 98.51%
2 Financials 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$5.04M 0.66%
507,041
27
$4.61M 0.61%
+202,500
28
$4.35M 0.57%
738,176
-26,227
29
$4.05M 0.53%
450,000
30
$3.7M 0.49%
549,250
31
$3.54M 0.47%
289,068
-208,487
32
$3.52M 0.46%
100,000
33
$3.38M 0.44%
396,835
34
$3.19M 0.42%
12,035
35
$3.16M 0.42%
300,000
36
$3.12M 0.41%
300,000
37
$2.5M 0.33%
64,000
-16,000
38
$2.48M 0.33%
275,169
-124,021
39
$2.44M 0.32%
700,421
40
$2.31M 0.3%
24,420
-36,630
41
$2M 0.26%
10,000
42
$1.87M 0.25%
78,131
-88,119
43
$1.8M 0.24%
40,550
-23,220
44
$1.63M 0.21%
3,580
45
$1.29M 0.17%
5,758
-5,037
46
$359K 0.05%
18,225
47
$317K 0.04%
25,000
48
$110K 0.01%
1,250
49
– –
-95,318
1
2